Oestrogen receptor-positive/HER2-negative, HER2-positive, and triple-negative phenotypes accounted for N = 33 (68.7%), N = 7 (14.6%) and N = 8 (16.7%) breast cancers, respectively. The gene discussed is ERBB2; the disease is breast cancer.